Loading data
ATERNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 68.98 m USD | 99.05 m USD | 142.57 m USD | 221.17 m USD | 247.77 m USD |
| Cost of revenue | 29.83 m USD | 37.55 m USD | 72.28 m USD | 115.65 m USD | 125.9 m USD |
| Gross profit | 39.15 m USD | 61.5 m USD | 70.29 m USD | 105.52 m USD | 121.86 m USD |
| Research and development expense | — | 0 USD | 4.62 m USD | 6.01 m USD | 9.84 m USD |
| Operating profit | -17.97 m USD | -11.82 m USD | -76.19 m USD | -178.16 m USD | -34.08 m USD |
| Interest expense | 957 k USD | 1.22 m USD | 2.13 m USD | 2.7 m USD | 13.25 m USD |
| Profit before tax | -18.94 m USD | -11.91 m USD | -75.43 m USD | -196.67 m USD | -235.49 m USD |
| Income tax expense | 41 k USD | -47 k USD | -867 k USD | -376 k USD | 532 k USD |
| Net income (reported basis) | -18.98 m USD | -11.86 m USD | -74.56 m USD | -196.29 m USD | -236.02 m USD |
| Basic earnings per share | -2.39 USD/share | -1.68 USD/share | -11.43 USD/share | -2.95 USD/share | -6.67 USD/share |
| Diluted earnings per share | — | — | — | -2.95 USD/share | -6.67 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.